Innate Pharma S.A. (NASDAQ:IPHA) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining us, and welcome to the Innate Pharma Third Quarter 2025 Business Update and Financial Results.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lion Point Didric Cederholm | 81,151 | $142,014 | 0.73% | |
| 2. | Millennium Management Israel Englander | 20,308 | $35,539 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 92,753 | $162,318 | 0% | |
| 2. | 46,394 | $81,190 | 0% | |
| 3. | 28,431 | $49,754 | 0% | |
| 4. | 5,204 | $9,106 | 0% | |
| 5. | 1,073 | $1,878 | 0% |